Riesgo de enfermedad tromboembólica venosa en pacientes hospitalizados no quirúrgicos. Grado de acuerdo entre la guía PRETEMED y las recomendaciones de la viii conferencia del American College of Chest Physicians

Medicina Clinica - Tập 139 - Trang 467-472 - 2012
Patricia Gallardo Jiménez1, Ricardo Guijarro Merino1, Verónica Vallejo Herrera1, David Sánchez Morales1, Aurora Villalobos Sánchez1, Juan Ignacio Perelló González-Moreno1, Ricardo Gómez-Huelgas1
1Servicio de Medicina Interna, Hospital Regional Universitario Carlos Haya, Málaga, España

Tài liệu tham khảo

Alikhan, 2004, Fatal pulmonary embolism in hospitalised patients: a necropsy review, J Clin Pathol, 57, 1254, 10.1136/jcp.2003.013581 Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 381, 10.1378/chest.08-0656 Alikhan, 2008, Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease, Am J Med, 121, 935, 10.1016/j.amjmed.2008.05.045 Guijarro Merino, 2008, Epidemiología hospitalaria de la enfermedad tromboembólica venosa en España, Med Clin (Barc), 131, 2, 10.1016/S0025-7753(08)76442-X Cohen, 2008, Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study, Lancet, 371, 387, 10.1016/S0140-6736(08)60202-0 Bergmann, 2010, Venous tromboembolism risk and prophylaxis in hospitalised medically ill patients, Thromb Haemost, 103, 736, 10.1160/TH09-09-0667 Nieto Rodríguez, 2009, Riesgo de enfermedad tromboembólica venosa y profilaxis antitrombótica en los pacientes ingresados en hospitales españoles (estudio ENDORSE), Med Clin (Barc), 133, 1, 10.1016/j.medcli.2009.01.040 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Leizorovicz, 2004, Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients, Circulation, 110, 874, 10.1161/01.CIR.0000138928.83266.24 Cohen, 2006, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, 332, 325, 10.1136/bmj.38733.466748.7C Dentali, 2007, Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients, Ann Intern Med, 146, 278, 10.7326/0003-4819-146-4-200702200-00007 Monreal, 2004, The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry, J Thromb Haemost, 2, 1892, 10.1111/j.1538-7836.2004.01012.x Hull, 2010, Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial, Ann Intern Med, 153, 8, 10.7326/0003-4819-153-1-201007060-00004 Medrano Ortega FJ, Navarro Puerto A, Vidal Serrano S, Alonso Ortiz del Río C, Gutierrez Tous R, Martín León I, et al. Guía PRETEMED 2007 sobre prevención de enfermedad tromboembólica venosa en patología médica. Córdoba: SADEMI; 2007. Disponible en: http://www.sademi.com/actividades/publicaciones/guia_medica_pretemed_2007.pdf Navarro Puerto, 2010, Guías clínicas para la prevención de la enfermedad tromboembólica venosa en ancianos, Med Clin (Barc), 135, 237, 10.1016/j.medcli.2009.05.035 Tapson, 2007, Venous thromboembolism prophylaxis in acutely ill hospitalised medical patients: findings from the international medical prevention registry on venous thromboembolism (IMPROVE), Chest, 132, 936, 10.1378/chest.06-2993 Amin, 2007, Thromboprophylaxis rates in US medical centers: success or failure?, J Thromb Haemost, 5, 1610, 10.1111/j.1538-7836.2007.02650.x Borobia, 2009, Riesgo de enfermedad tromboembólica y estudio de utilización de tromboprofilaxis en pacientes médicos hospitalizados y al alta hospitalaria, Rev Clin Esp, 209, 15, 10.1016/S0014-2565(09)70353-4 Kahn, 2007, Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada, Thromb Res, 119, 145, 10.1016/j.thromres.2006.01.011 Amin, 2010, Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start), J Thromb Thrombolysis, 29, 326, 10.1007/s11239-009-0361-z Villar Fernández, 2004, Evaluación de la utilización de heparinas de bajo peso molecular como profilaxis de tromboembolismo venoso en pacientes de medicina interna, Farm Hosp, 28, 402 Roderick, 2005, Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis, Health Technol Assess, 9, 1, 10.3310/hta9490 Dennis, 2009, Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial, Lancet, 373, 1958, 10.1016/S0140-6736(09)60941-7 Decousus, 2011, Factors at admission associated with bleeding risk in medical patients. Findings from the IMPROVE investigators, Chest, 139, 69, 10.1378/chest.09-3081 Spyropoulos, 2011, Predictive and associative models to identify hospitalized medical patients at risk for venous thromboembolism, Chest, 140, 706, 10.1378/chest.10-1944 Kucher, 2005, Electronic alerts to prevent venous thromboembolism among hospitalized patients, N Engl J Med, 352, 969, 10.1056/NEJMoa041533 Páramo, 2009, Enfermedad tromboembólica venosa: una llamada urgente a la acción, Med Clin (Barc), 133, 547, 10.1016/j.medcli.2009.02.049